Astellas Pharma Inc IZERVAY Briefing Transcript
[Interpreted] Good morning. Thank you very much for joining Astellas Pharma's IZERVAY online meeting today out of your very busy schedule. I'm delighted to serve as emcee today. I'm Ikeda, Chief Communications and IR Officer. Thank you very much for your time.
Today, GATHER2 study's 24-month data presented at the AAO, American Academy of Ophthalmology, will be explained by our clinical development person-in-charge. Today's participants: Iveric Bio's Senior Vice President and Chief Development Officer, Dhaval Desai; Iveric Bio's Vice President, Product Strategy and Innovation, Erin Henry; Vice President, Head of Cell and Gene Therapy Development, Carolyn Sasse.
Today, we provide simultaneous interpreting between Japanese and English, including Q&A. We cannot guarantee the accuracy of simultaneous translation. On the Zoom menu screen, please select the language of your preference. If you select original, you can listen to the original sound without going through simultaneous interpretation.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
